TAAs trigger T lymphocyte responses via the major histocompatibility complex (MHC) and can lead to the destruction of tumor cells through cytotoxicity mediated by CD8 cells and antibody-dependent complement activation [8, 30]. Here, HLA-C is linked to neoplasm.